These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


227 related items for PubMed ID: 12887821

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Characteristics of gene structure in facioscapulohumeral muscular dystrophy-related 4q35 subtelomere and genotype-phenotype correlation in Chinese Han population].
    Wang ZQ, Wu ZY, Wang N, Lin MT, Murong SX.
    Zhonghua Yi Xue Za Zhi; 2009 Feb 10; 89(5):304-9. PubMed ID: 19563705
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A new dosage test for subtelomeric 4;10 translocations improves conventional diagnosis of facioscapulohumeral muscular dystrophy (FSHD).
    van der Maarel SM, Deidda G, Lemmers RJ, Bakker E, van der Wielen MJ, Sandkuijl L, Hewitt JE, Padberg GW, Frants RR.
    J Med Genet; 1999 Nov 10; 36(11):823-8. PubMed ID: 10544225
    [Abstract] [Full Text] [Related]

  • 6. The Facioscapulohumeral muscular dystrophy region on 4qter and the homologous locus on 10qter evolved independently under different evolutionary pressure.
    Rossi M, Ricci E, Colantoni L, Galluzzi G, Frusciante R, Tonali PA, Felicetti L.
    BMC Med Genet; 2007 Mar 02; 8():8. PubMed ID: 17335567
    [Abstract] [Full Text] [Related]

  • 7. [Gene diagnosis of facioscapulohumeral muscular dystrophy].
    Zhang JL, Shen DG, Zhou PK, Liu JW, Jia N, Liu H, Wang HB, Yang SX, Frants RR.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Jun 02; 20(3):232-4. PubMed ID: 12778451
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Molecular combing reveals allelic combinations in facioscapulohumeral dystrophy.
    Nguyen K, Walrafen P, Bernard R, Attarian S, Chaix C, Vovan C, Renard E, Dufrane N, Pouget J, Vannier A, Bensimon A, Lévy N.
    Ann Neurol; 2011 Oct 02; 70(4):627-33. PubMed ID: 22028222
    [Abstract] [Full Text] [Related]

  • 17. Typical facioscapulohumeral dystrophy phenotype in patients without FSHD 4q35 deletion.
    Krasnianski M, Neudecker S, Eger K, Jakubiczka S, Zierz S.
    J Neurol; 2003 Sep 02; 250(9):1084-7. PubMed ID: 14504970
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Methylation of the FSHD syndrome-linked subtelomeric repeat in normal and FSHD cell cultures and tissues.
    Tsien F, Sun B, Hopkins NE, Vedanarayanan V, Figlewicz D, Winokur S, Ehrlich M.
    Mol Genet Metab; 2001 Nov 02; 74(3):322-31. PubMed ID: 11708861
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.